BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 4, 2004
View Archived Issues
Therapeutic benefits of statins in heart transplant patients
Read More
Levosimendan in intensive care
Read More
CpG ODN 1826 activates uveitogenic T-cells in mice
Read More
Regression of ocular neovascularization by periocular PEDF gene therapy
Read More
Antineoplastic effects of pioglitazone on malignant tumor growth in rat glioma model
Read More
NDA submission for Glumetza
Read More
Greater benefits found for calcium acetate in hemodialysis patients with hyperphosphatemia
Read More
Two novel CXCR2 antagonists and their use presented by AstraZeneca
Read More
New non-nucleoside HIV RT inhibitors identified at Boehringer Ingelheim
Read More
Lilly claims TGF-beta receptor kinase inhibitors for cancer and other disorders
Read More
Novel selective RARalpha ligands developed by Allergan researchers
Read More
Axys (Celera Genomics) patent covers new cathepsin B inhibitors for cancer, arthritis, etc.
Read More
New antiangiogenic agents in early development at Boehringer Ingelheim
Read More
Cognitive effects of SGS-742 in patients with mild cognitive impairment
Read More
Novel gamma-secretase inhibitor for Alzheimer's disease therapy
Read More
Tyrosine kinase inhibitor blocks choroidal neovascularization
Read More
PARP inhibition protects neurons and white matter from focal cerebral stroke
Read More
2'-FdC effective against Borna disease virus
Read More
Trehalose opens new approach to treatment of polyglutamine diseases
Read More
Celgene to stop Revlimid phase III trials in melanoma
Read More
Ceregene to advance Alzheimer's gene therapy
Read More
Genaissance amends license agreements for cardiac ion channel gene patents
Read More
GW Pharmaceuticals to submit more information for U.K. review of Sativex
Read More
Interim results for first phase III trial of AERx iDMS
Read More
Sepracor to phase out Astelin copromotion agreement with MedPointe
Read More
Abbott continues shift toward highly innovative business during Q1 2004
Read More
Genentech updates product development events during Q1 2004
Read More
Antigenics highlights Q1 developments
Read More
SPM-927 reduces pain and improves sleep and function in diabetic neuropathy patients
Read More